- Peter T Sawicki, institute director,
- Hilda Bastian, head of health information department
- 1German Institute for Quality and Efficiency in Health Care, Dillenburger Strasse 27, Cologne 51105, Germany
- Correspondence to: H Bastian hilda.bastian{at}iqwig.de
- Accepted 26 August 2008
Germany was the first country to develop a national system to insure people against medical costs. It was in 1883 that one of the most conservative of politicians, Otto von Bismarck, laid down the first foundation slab for the modern European welfare state. Scientific and medical research was a pillar of Germany’s economic and industrial development strategy from that time as well. These policies and structures helped develop an advanced, highly medicalised, and technological healthcare system. In recent decades, a combination of wealth and strong social welfare infrastructure has insulated Germany from having to ask too many hard questions about the value of one of the world’s most expensive healthcare systems. This article looks at the challenges of maintaining the legacy of access to health care for all, a growing commitment to patient empowerment, and the changing role of evidence in western Europe’s most populous country.
Universal access to all necessary health care
The roots of Germany’s commitment to universal access to health care are deep. It was clear to Bismarck and his contemporaries that the only way to protect individuals from catastrophic health problems was if the whole community shouldered the risk. They could not have foreseen, though, just how expensive health care was going to become 125 years later. Back then, medical insurance was politically the easiest of the social security planks to achieve.1
Fast forward to 2008, and the costs of statutory health insurance are now split roughly 50:50 between employers and employees, with the government paying for coverage of welfare recipients. Statutory insurance covers over 90% of the population. The remainder are covered by private insurance. Cost control in health has …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012